Skip to content
Screener

Asset write-downs at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Danaher logo
DanaherDHR
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$5.0B-9.5%
Gross profit$2.3B-12.1%
Operating income$663.0M-24.8%
Net income$377.0M-34.3%
EPS (diluted)$1.64-18.0%

Balance sheet

See full
Cash & equivalents$708.0M-11.3%
Total debt$13.5B-22.9%
Total equity$24.4B-4.1%
Total assets$50.7B-7.6%

Cash flow

See full
Operating cash flow$776.0M-51.1%
CapEx$143.0M-24.3%
Free cash flow$633.0M-54.7%

Valuation

See full
Market cap$48.79B-1.3%
Enterprise value$61.59B-6.9%
P/E51.9×+20.7×
P/S2.3×-0.1×

Profitability

See full
Gross margin46.4%+1.7pp
Operating margin9.6%-1.7pp
Net margin4.5%-3.2pp
FCF margin13.1%

Returns & leverage

See full
Return on equity3.8%-2.4pp
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The source filing: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:34 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000010795-26-000026
Line itemSix Months Ended March 31, 2026Six Months Ended March 31, 2025
Deferred income taxes(44)(259)
Change in operating assets and liabilities(417)(1,070)
Pension obligation(4)(3)
Asset impairment charges450
Impacts of debt extinguishment(122)
Other, net(91)254
Net Cash Provided by Continuing Operating Activities1,328489
Investing Activities

Item 1. Financial Statements (Unaudited)

FAQ

What is Becton, Dickinson and Company's asset write-downs?
Becton, Dickinson and Company (BDX) reported asset write-downs of $450M in Q1 2026.

Ask your AI about Becton, Dickinson and Company's asset write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude